William W. Lockwood - Concepedia

Author

William W. Lockwood

Also Known As

Bernard Brodie, Cyril Black, Harold Lasswell, Lockwood, William, Lockwood, William W., Vickers, W Lockwood, W W Lockwood, W. Lockwood, W. W. Lockwood

376

Publications

7.4K

Citations

H-Index

110

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Memorial Sloan Kettering Cancer Center The University of Texas Southwestern Medical Center Cancer Genetics (United States)

About

William W. Lockwood is an author at University of British Columbia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	2.4K
2	Business	8	8	560
3	Language Studies	8	8	551
4	Engineering	6	6	785
5	Natural Sciences	4	4	263

William W. Lockwood

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
<i>PIK3CA</i> Mutations and Copy Number Gains in Human Lung Cancers Hiromasa Yamamoto, Hisayuki Shigematsu, Masaharu Nomura, Cancer Research EngineeringPathologyCancer BiologyTumor BiologyOncology	2008	427
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins William W. Lockwood, Kreshnik Zejnullahu, James E. Bradner, Proceedings of the National Academy of Sciences	2012	344
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance Jonathan Lim, Alberto Delaidelli, Sean W. Minaker, Proceedings of the National Academy of Sciences	2019	297
Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells Junichi Soh, Naoki Okumura, William W. Lockwood, PLoS ONE	2009	224
Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines Jeet Gandhi, Jianling Zhang, Yang Xie, PLoS ONE	2009	204
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma Arun M. Unni, William W. Lockwood, Kreshnik Zejnullahu, eLife Human Lung AdenocarcinomasLung AdenocarcinomaPathologySynthetic LethalityCancer Biology	2015	198
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers Alexander Drilon, Romel Somwar, Biju Mangatt, Cancer Discovery	2018	198
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer Yibo Xue, Brian Meehan, Zheng Qing Fu, Nature Communications	2019	182
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer Daniel T. Starczynowski, William W. Lockwood, Sophie Deléhouzée, Journal of Clinical Investigation	2011	171
Political Change and Industrial Development in Japan: Government Enterprise, 1868-1880. William W. Lockwood, Thomas C. Smith The Far Eastern Quarterly Government EnterpriseIndustrial PolicyBusiness HistoryJapanese HistoryEast Asian Studies	1956	168

Page 1